
Ocutec
Ocutec | Visionary Science | Contact Lenses - Visionary Science Specialists.
GBP | 2014 | 2015 | 2016 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 |
% EBITDA margin | (181 %) | - | - |
Profit | 0000 | 0000 | 0000 |
% profit margin | (249 %) | - | - |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Ocutec is a pioneering company specializing in the development and manufacturing of advanced contact lenses using proprietary OcuPEG material technology. The company's flagship product, the PEGLens, is designed to offer exceptional comfort and unprecedented hydrogel oxygen performance, making it ideal for both daily and monthly replacement. Ocutec serves a diverse clientele, including optometrists, ophthalmologists, and consumers seeking high-quality contact lenses. Operating in the vision care market, Ocutec employs a business model that focuses on innovation and quality, leveraging its patented technology to create a competitive edge. The company generates revenue through direct sales to eye care professionals and partnerships with optical retailers. By minimizing lens surface dehydration and limiting protein and lipid deposition, Ocutec's PEGLens ensures a superior user experience, setting it apart from traditional contact lenses.
Keywords: OcuPEG, PEGLens, hydrogel, contact lenses, vision care, optometrists, ophthalmologists, oxygen performance, surface dehydration, lipid deposition.